Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis

Tuberculosis

Volumn 90, Issue 3, 2010, Pages 188-196

  Yadav, Awadh B ^a   Muttil, Pavan ^a   Singh, Amit K ^a   Verma, Rahul K ^a   Mohan, Mradul ^a   Agrawal, Atul K ^a   Verma, Ajay S ^a   Sinha, Sudhir K ^a   Misra, Amit ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Apoptosis; Cytokines; Macrophage; Microspheres; Nitric oxide

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYTOKINE; DRUG CARRIER; GAMMA INTERFERON; ISONIAZID; MICROPARTICLE; NITRIC OXIDE; RIFABUTIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BACTERIAL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; TUBERCULOSIS;

ANIMALS; ANNEXIN A5; APOPTOSIS; CASPASES; CELL LINE; CELL-DERIVED MICROPARTICLES; CYTOKINES; INTERFERON-GAMMA; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77952541390     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.03.001     Document Type: Article

References (43)

1. O'Hara P., and Hickey A.J. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization. Pharm Res 17 (2000) 955-961
2. Sharma R., Saxena D., Dwivedi A.K., and Misra A. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis. Pharm Res 18 (2001) 1405-1410
3. Muttil P., Kaur J., Kumar K., Yadav A.B., Sharma R., and Misra A. Inhalable microparticles containing large payload of anti-tuberculosis drugs. Eur J Pharm Sci 32 (2007) 140-150
4. Verma R.K., Kaur J., Kumar K., Yadav A.B., and Misra A. Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice. Antimicrob Agents Chemother 52 (2008) 3195-3201
5. Sharma R., Muttil P., Yadav A.B., Rath S.K., Bajpai V.K., Mani U., et al. Uptake of inhalable microparticles affects defence responses of macrophages infected with Mycobacterium tuberculosis H37Ra. J Antimicrob Chemother 59 (2007) 499-506
6. Yadav A.B., and Misra A. Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactercidal activity. Antimicrob Agents Chemother 51 (2007) 3740-3742
7. Flynn J.L., and Chan J. Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 15 (2003) 450-455
8. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., and Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99 (2002) 1503-1508
9. Kahnert A., Seiler P., Stein M., Bandermann S., Hahnke K., Mollenkopf H., et al. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur J Immunol 36 (2006) 631-647
10. Flynn J.L., and Chan J. What's good for the host is good for the bug. Trends Microbiol 13 (2005) 98-102
11. Spira A., Carroll J.D., Liu G., Aziz Z., Shah V., Kornfeld H., et al. Apoptosis genes in human alveolar macrophages infected with virulent or attenuated Mycobacterium tuberculosis: a pivotal role for tumor necrosis factor. Am J Respir Cell Mol Biol 29 (2003) 545-551
12. Keane J., Balcewicz-Sablinska M.K., Remold H.G., Chupp G.L., Meek B.B., Fenton M.J., et al. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis. Infect Immun 65 (1997) 298-304
13. Keane J., Shurtleff B., and Kornfeld H. TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner. Tuberculosis (Edinb) 82 (2002) 55-61
14. Molloy A., Laochumroonvorapong P., and Kaplan G. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin. J Exp Med 180 (1994) 1499-1509
15. Keane J., Remold H.G., and Kornfeld H. Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages. J Immunol 164 (2000) 2016-2020
16. Lee J., Remold H.G., Ieong M.H., and Kornfeld H. Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway. J Immunol 176 (2006) 4267-4274
17. O'Sullivan M.P., O'Leary S., Kelly D.M., and Keane J. A caspase-independent pathway mediates macrophage cell death in response to Mycobacterium tuberculosis infection. Infect Immun 75 (2007) 1984-1993
18. Riendeau C.J., and Kornfeld H. THP-1 cell apoptosis in response to Mycobacterial infection. Infect Immun 71 (2003) 254-259
19. Oddo M., Renno T., Attinger A., Bakker T., MacDonald H.R., and Meylan P.R. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol 160 (1998) 5448-5454
20. Kaur J., Muttil P., Verma R.K., Kumar K., Yadav A.B., Sharma R., et al. A hand-held apparatus for "nose-only" exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages. Eur J Pharm Sci 34 (2008) 56-65
21. Hestvik A.L., Hmama Z., and Av-Gay Y. Mycobacterial manipulation of the host cell. FEMS Microbiol Rev 29 (2005) 1041-1050
22. Kanuka H., Hisahara S., Sawamoto K., Shoji S., Okano H., and Miura M. Proapoptotic activity of Caenorhabditis elegans CED-4 protein in Drosophila: implicated mechanisms for caspase activation. Proc Natl Acad Sci USA 96 (1999) 145-150
23. Duan L., Gan H., Golan D.E., and Remold H.G. Critical role of mitochondrial damage in determining outcome of macrophage infection with Mycobacterium tuberculosis. J Immunol 169 (2002) 5181-5187
24. Gan H., He X., Duan L., Mirabile-Levens E., Kornfeld H., and Remold H.G. Enhancement of antimycobacterial activity of macrophages by stabilization of inner mitochondrial membrane potential. J Infect Dis 191 (2005) 1292-1300
25. Chen M., Gan H., and Remold H.G. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J Immunol 176 (2006) 3707-3716
26. Flynn J., and Bloom B. Role of T1 and T2 cytokines in the response to Mycobacterium tuberculosis. Ann N Y Acad Sci 795 (1996) 137-146
27. Chiu B., Freeman C., Stolberg V., Komuniecki E., Lincoln P., Kunkel S., et al. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am J Respir Cell Mol Biol 29 (2003) 106-116
28. Stenger S. Immunological control of tuberculosis: role of tumour necrosis factor and more. Ann Rheum Dis 64 Suppl. 4 (2005) 24-28
29. Chan E.D., Chan J., and Schluger N.W. What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am J Respir Cell Mol Biol 25 (2001) 606-612
30. Wang C.H., Liu C.Y., Lin H.C., Yu C.T., Chung K.F., and Kuo H.P. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur Respir J 11 (1998) 809-815
31. Tunctan B., Okur H., Calisir C.H., Abacioglu H., Cakici I., Kanzik I., et al. Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis. Pharmacol Res 37 (1998) 219-226
32. Yan B.S., Pichugin A.V., Jobe O., Helming L., Eruslanov E.B., Gutierrez-Pabello J.A., et al. Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guerin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity. J Immunol 179 (2007) 6919-6932
33. Carranza C., Juarez E., Torres M., Ellner J.J., Sada E., and Schwander S.K. Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts. Am J Respir Crit Care Med 173 (2006) 238-245
34. Sable S.B., Goyal D., Verma I., Behera D., and Khuller G.K. Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins. Eur Respir J 29 (2007) 337-346
35. Bose M., Farnia P., Sharma S., Chattopadhya D., and Saha K. Nitric oxide dependent killing of mycobacterium tuberculosis by human mononuclear phagocytes from patients with active tuberculosis. Int J Immunopathol Pharmacol 12 (1999) 69-79
36. Sharma S., Sharma M., and Bose M. Mycobacterium tuberculosis infection of human monocyte-derived macrophages leads to apoptosis of T cells. Immunol Cell Biol 87 (2009) 226-234
37. Rojas M., Barrera L.F., and Garcia L.F. Induction of apoptosis in murine macrophages by Mycobacterium tuberculosis is reactive oxygen intermediates-independent. Biochem Biophys Res Commun 247 (1998) 436-442
38. Prior S., Gander B., Blarer N., Merkle H., Subira M., Irache J., et al. In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres. Eur J Pharm Sci 15 (2002) 197-207
39. Sansonetti P.J. The innate signaling of dangers and the dangers of innate signaling. Nat Immunol 7 (2006) 1237-1242
40. Gil D., Garcia L.F., and Rojas M. Modulation of macrophage apoptosis by antimycobacterial therapy: physiological role of apoptosis in the control of Mycobacterium tuberculosis. Toxicol Appl Pharmacol 190 (2003) 111-119
41. Berrington W.R., and Hawn T.R. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter?. Immunol Rev 219 (2007) 167-186
42. Thuong N.T., Dunstan S.J., Chau T.T., Thorsson V., Simmons C.P., Quyen N.T., et al. Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles. PLoS Pathog 4 (2008) e1000229
43. Young D.B. Stimulate the phagocytes. Tuberculosis (Edinb) 81 (2001) 257-258